Listing & Compliance Notices

BIOTRICITY INC. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

“May 1, 2024, Biotricity Inc. (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that it is not in compliance with the Nasdaq Listing Rule 5620(a) (the “Rule”) requiring that the Company hold an annual meeting of stockholders within 12 months of the end of its fiscal year. The notification received has no immediate effect on the Company’s continued listing on the Nasdaq Capital Market, subject to its compliance with the other continued listing requirements. In the letter dated May 1, 2024, Nasdaq notified the Company that this serves as an additional basis for del”

Acutus Medical, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b), 5810(d)(2)).

“April 30, 2024, the Staff notified the Company that it has not regained compliance with Listing Rule 5550(a)(2). The Staff also notified the Company, as a separate basis for delisting pursuant to Listing Rule 5810(d)(2), that the Company is not in compliance with Listing Rule 5550(b) for failure to maintain stockholders’ equity of at least $2.5 million, or either of the alternatives to compliance with this standard ((i) market value of listed securities of $35 million or (ii) net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last thre”

Acutus Medical, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A), 5550(a)(2), 5810(d)(2), 5550(b)).

“April 30, 2024, the Staff notified the Company that it has not regained compliance with Listing Rule 5550(a)(2). The Staff also notified the Company, as a separate basis for delisting pursuant to Listing Rule 5810(d)(2), that the Company is not in compliance with Listing Rule 5550(b) for failure to maintain stockholders’ equity of at least $2.5 million, or either of the alternatives to compliance with this standard ((i) market value of listed securities of $35 million or (ii) net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last thre”

ClearSign Technologies Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“May 2, 2024, ClearSign Technologies Corporation (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days beginning on March 20, 2024 and ending on May 1, 2024, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a perio”

NeuBase Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“May 2, 2024, the Staff notified the Company that it has not regained compliance with the Minimum Bid Price Requirement (the “Delisting Determination”) and that it is ineligible for a second 180 calendar day period to regain compliance as it did not provide information regarding its intent to cure the bid price deficiency. The Staff informed the Company that unless it requests an appeal of the Delisting Determination to a Hearings Panel by May 9, 2024, the Company’s common stock will be scheduled for delisting from the Nasdaq Capital Market and will be suspended at the opening of business on Ma”

BRAINSTORM CELL THERAPEUTICS INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“May 1, 2024, the Company received a staff determination letter (“Staff Letter”) from the Staff of Nasdaq indicating that the Company had not regained compliance with the Minimum Bid Price Requirement by April 29, 2024. Pursuant to the Nasdaq Listing Rules and the Staff Letter, if the Company does not request an appeal of the Staff’s determination by May 8, 2024, the Company’s securities will be scheduled for delisting from The Nasdaq Capital Market and will be suspended at the opening of business on May 10, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the”

SEELOS THERAPEUTICS, INC. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“April 30, 2024, the Company received written notice (the “Bid Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until October 28, 2024, to regain compliance. The Bid Notice states that the Nasdaq”

MANGOCEUTICALS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“filed by the Company with the Commission on November 7, 2023, on November 3, 2023, the Company received a letter from Nasdaq notifying the Company that it was not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) (the “ Rule ”), which requires companies listed on the Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000. In the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, the Company reported stockholders’ equity of $1,354,821, which is”

MANGOCEUTICALS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 30, 2023, the Company received written notice (the “ Notification Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that it was not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues”

Twelve Seas Investment Co. II received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“result of its failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2023 (the “ Form 10-K ”). The Notice advised the Company that it was not in compliance with Nasdaq’s continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1). As reported by the Company in its Form 12b-25 filed with the Securities and Exchange Commission (the “ SEC ”) on April 2, 2024, the Company was unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense. The extension period provided under SEC R”

ZW Data Action Technologies Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“May 1, 2024, the Company received another notice (the “Second Notice”) from Nasdaq indicating that, while the Company has not regained compliance with the Bid Price Requirement, Nasdaq has determined that the Company is eligible for an additional 180-day period, or until October 28, 2024, to regain compliance. According to the Second Notice from Nasdaq, the Staff’s determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other Nasdaq initial listing standards, with the exception of the minimum bid price requiremen”

Agriculture & Natural Solutions Acquisition Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2), 5605(c)(4)).

“April 30, 2024, the Company received a letter from Nasdaq confirming such non-compliance and confirming that, in accordance with Nasdaq Rule 5605(c)(4), Nasdaq will provide the Company a cure period in order to regain compliance as follows: • Until the earlier of the Company’s next annual shareholders’ meeting or March 26, 2025; or • If the next annual shareholders’ meeting is held before September 23, 2024, then the Company must evidence compliance no later than September 23, 2024. The foregoing has no immediate effect on the Company’s Nasdaq listing and its securities will continue to be lis”

Thunder Bridge Capital Partners IV, Inc. received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2), 5810(b)).

“had no immediate effect on the listing of the Company’s securities, and its securities continued to trade on the Nasdaq Global Market. On October 26, 2023, the Company filed a Current Report on Form 8-K to disclose its receipt of the Total Stockholders Notice in accordance with Nasdaq Listing Rule 5810(b). On December 8, 2023, the Company submitted its plan to meet the requirements under the Total Stockholders Rule. On December 13, 2023, the Company received a letter from the Nasdaq Staff granting it until April 22, 2024 to file documentation with the Nasdaq Staff from its transfer agent, or”

PaxMedica, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“April 30, 2024, The Nasdaq Stock Market LLC (“Nasdaq”) notified PaxMedica, Inc. (the “Company”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common stock and that trading of the Company’s securities will be suspended at the open of trading on May 2, 2024. The Company expects its common stock will be eligible for quotation on the OTC Pink Market under its existing symbol, “PXMD.” The Panel reached its decision because the Company is in violation of the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). The Company has 15 days after the date i”

Butterfly Network, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“April 26, 2024, the Company received a notification letter (the “Notice”) from the New York Stock Exchange (the “NYSE”) advising that because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period, it is not in compliance with Section 802.01C of the NYSE Listed Company Manual (“Section 802.01C”). The Company’s common stock will continue to be listed and traded on the NYSE, subject to the Company’s compliance with other NYSE continued listing standards. Pursuant to Section 802.01C, the Company has a period of six months following the”

Accelerate Diagnostics, Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“April 26, 2024, Accelerate Diagnostics, Inc. (the “Company”) received written notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock had closed below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq rules, the Company has been provided an initial period of 180 calendar days, or unti”

Nature's Miracle Holding Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5450(b)(2)(A), 5810(c)(3)(D)).

“April 26, 2024, Nature’s Miracle Holding Inc. (the “Company”) received a notification letter (the “Notification Letter on MVPHS”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with the minimum Market Value of Publicly Held Shares (the “MVPHS”) set forth in Nasdaq Listing Rule 5450(b)(2)(C) for continued listing on Nasdaq, which requires a minimum MVPHS of $15,000,000 (the “MVPHS Requirement”), since the Company failed to meet the MVPHS Requirement for a period of 30 consecutive business days from March 13, 2024 to April 25, 2024. The Notification Letter on M”

ProSomnus, Inc. received a nasdaq delisting notice notice regarding other.

“not in compliance with Nasdaq’s minimum market value of listed securities of $50,000,000, Nasdaq’s minimum market value of publicly held shares of $15,000,000, or Nasdaq’s minimum bid price requirement of $1.00, each of which was required for continued listing on Nasdaq. The Company’s securities were suspended from trading on Nasdaq on April 18, 2024 and have not traded on Nasdaq since that time. On April 25, 2024, Nasdaq filed a Form 25 with the SEC notifying the SEC of Nasdaq’s determination to remove the Company’s securities from listing on Nasdaq. The delisting will become effective ten da”

PHP Ventures Acquisition Corp. received a nasdaq hearing update notice regarding market value (rules 5550(b)(2)).

“notice from Nasdaq (the “ MVLS Notice ”) stating that the Company’s market value of listed securities (“ MVLS ”) for the last 30 consecutive business days (from March 6, 2023 to April 14, 2023), was below the required minimum of $35 million for continued listing on Nasdaq under Nasdaq Listing Rule 5550(b)(2) (the “ MVLS Requirement ”). On October 9, 2023, the Company submitted its plan to regain compliance with Nasdaq by completing its initial business combination pursuant to the Business Combination Agreement dated as of December 8, 2022 (the “ Business Combination Agreement ”) by and among”

SMART FOR LIFE, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5550(a)(2), 5810(c)(3)(A)(iv)).

“l no later than April 24, 2024. On April 24, 2024, the Company received an additional notification letter from Nasdaq notifying the Company that its securities had closed at less than $1.00 per share over the previous 30 consecutive business days, and, as a result, does not comply with Listing Rule 5550(a)(2) (the “Bid Rule”). The notification letter further stated that while a company would normally be afforded a 180-calendar day period to demonstrate compliance with the Bid Rule, pursuant to Listing Rule 5810(c)(3)(A)(iv), the Company is not eligible for any compliance period specified in Ru”

SMART FOR LIFE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“April 24, 2024. On April 24, 2024, the Company received an additional notification letter from Nasdaq notifying the Company that its securities had closed at less than $1.00 per share over the previous 30 consecutive business days, and, as a result, does not comply with Listing Rule 5550(a)(2) (the “Bid Rule”). The notification letter further stated that while a company would normally be afforded a 180-calendar day period to demonstrate compliance with the Bid Rule, pursuant to Listing Rule 5810(c)(3)(A)(iv), the Company is not eligible for any compliance period specified in Rule 5810(c)(3)(A)”

RF Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

“April 29, 2024, RF Acquisition Corp., a Delaware corporation (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, the Company is not in compliance with Nasdaq Listing Rule 5450(a)(2) (the “Minimum Total Holders Rule”), which requires the Company to have at least 400 total holders for continued listing on the Nasdaq Global Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Co”

Plum Acquisition Corp. III received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 25, 2024, Plum Acquisition Corp. III (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has failed to comply with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required annual financial reports with the Securities and Exchange Commission (the “Commission”). This notification has no immediate effect on the listing of the Company’s shares on Nasdaq. However, if the Company fails to timely regain compliance with the Nasdaq Listing Rule”

SPRUCE BIOSCIENCES, INC. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).

“April 26, 2024, Spruce Biosciences, Inc. (the “ Company ”) received a notice from The Nasdaq Global Select Market (“ Nasdaq ”) that the Company is not in compliance with Nasdaq’s Listing Rule 5450(a)(1), as the minimum bid price of the Company’s common stock has been below $1.00 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Global Select Market. The Company has 180 calendar days, or until October 23, 2024, to regain compliance with the minimum bid price requirement. To”

Scorpius Holdings, Inc. received a nyse_american compliance regained notice regarding late filing (rules 1007).

“April 29, 2024, Scorpius Holdings, Inc. (the “Company”) received a notice (the “Notice”) from NYSE Regulation (the "Notice") stating that the Company has now regained compliance with Section 1007 of the NYSE American Company Guide as a result of its filing of its Annual Report on Form 10-K for the year ended December 31, 2023 on April 26, 2024. As previously reported, on April 17, 2024, the Company received a notice from NYSE Regulation that the Company was not on such date in compliance with the continued listing standards of the NYSE American LLC under the timely filing criteria included in”

SRx Health Solutions, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

“April 24, 2024, notifying the Company that it is no longer in compliance with NYSE American continued listing standards. Specifically, the letter states that the Company is not in compliance with the continued listing standards set forth in Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide (the “Company Guide”). Section 1003(a)(ii) requires a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. Section 1003(a)(iii) requires a”

SHINECO, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“April 26, 2024, Shineco Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock (the “Common Stock”) for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”). The Notice has no immedi”

SANGAMO THERAPEUTICS, INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“April 24, 2024, Sangamo Therapeutics, Inc. (the “Company”) received a deficiency notice, or the Notice, from the Listing Qualifications Staff, or the Staff, of The Nasdaq Stock Market LLC, or Nasdaq, notifying the Company that, for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Global Select Market. In accordance with Nasd”

DYNATRONICS CORP received a nasdaq noncompliance notice notice regarding other (rules 5250(f)).

“April 23, 2024, Dynatronics Corporation (the "Company") received written notice ("Fee Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it had not paid certain fees required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5250(f). The Company's past due fee balance was $49,500 as of the date of the Fee Notice. The Fee Notice provided that if the Company elects not to appeal by April 30, 2024, then this lack of payment would lead to the suspension of the trading of the Company's common stoc”

Adamas One Corp. received a nasdaq noncompliance notice notice regarding other (rules 5250(f), 5250(c)(1)).

“April 23, 2024, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company of its noncompliance with two additional rules: (1) Nasdaq Listing Rule 5250(f) (the “Fees Rule”) for the Company’s failure to pay its Nasdaq annual listing fee; and (2) Nasdaq Listing Rule 5250(c)(1) (the “Filings Rule”) for the Company’s previously disclosed failure to timely file its (a) Annual Report on Form 10-K for the year ended September 30, 2023 and (b) Quarterly Report on Form 10-Q for the period ended December 31, 2023. The Company’s vi”

Liberty Resources Acquisition Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 23, 2024, Liberty Resources Acquisition Corp. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The NASDAQ Stock Market LLC (“ Nasdaq ”) indicating that because the Company has not yet filed its Form 10-K for the year ended December 31, 2023, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1). The Notice states the Company should present its views with respect to this deficiency to the Nasdaq Listing and Hearing Review Council (the “ Council ”) in writing no later than April 30, 2024. The Notice further states tha”

Direct Selling Acquisition Corp. received a nyse delisting notice notice regarding market value (rules 802.01B).

“April 29, 2024, Direct Selling Acquisition Corp. (“DSAQ” or the “Company”) received a notice (the “Delisting Notice”) from The New York Stock Exchange (“NYSE”) stating that NYSE has determined to delist the Company’s Class A common stock and units (collectively, the “Securities”) from NYSE and that trading in the Securities on NYSE had been suspended, effective at the close of trading on April 29, 2024. NYSE reached its decision pursuant to Rule 802.01B of the NYSE Listed Company Manual because the Company did not meet NYSE’s continued listing standard that requires listed acquisition companie”

Embrace Change Acquisition Corp. received a nasdaq delisting notice notice regarding other (rules 5250(f)).

“received a delisting determination letter from the Listing Qualifications of The Nasdaq Stock Market LLC advising the Company that the Company has not paid its assessed fees required by Listing Rule 5250(f). The Company subsequently paid the outstanding fee. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 29, 2024 EMBRACE CHANGE ACQUISITION CORP. By: /s/ Jingyu Wang Name: Jingyu Wang Title: Chief Executive Officer 2”

Fortune Rise Acquisition Corp received a nasdaq delisting notice notice regarding late filing (rules 5250(f)).

“April 24, 2024, the Company received an additional notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(f) (the “Fee Payment Rule”) because it has not paid certain fees to Nasdaq, which serves as an additional basis for delisting the Company’s securities from the Nasdaq Capital Market. The failure to comply with the Fee Payment Rule will also be considered by the Panel at the Hearing. The suspension of the Company’s securities and the termination of registration of”

Clean Energy Special Situations Corp. received a nasdaq delisting notice notice regarding late filing (rules 5810(d)(2)).

“April 23, 2024, Clean Energy Special Situations Corp. (the “ Company ”) received a notification letter (the “ Notification Letter ”) from the Listing Qualifications Department (the “ Staff ”) of the Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company was not in compliance with Nasdaq’s continued listing standards (the “ Rules ”), because the Company had not paid certain fees required by Listing Rule 5250(f). Additionally, the Staff noted that the Company had failed to file its Annual Report on Form 10-K for the period ended December 31, 2023 (the “ 2023 Form 10-K ”), which serves”

Clean Energy Special Situations Corp. received a nasdaq delisting notice notice regarding other (rules 5250(f)).

“April 23, 2024, Clean Energy Special Situations Corp. (the “ Company ”) received a notification letter (the “ Notification Letter ”) from the Listing Qualifications Department (the “ Staff ”) of the Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company was not in compliance with Nasdaq’s continued listing standards (the “ Rules ”), because the Company had not paid certain fees required by Listing Rule 5250(f). Additionally, the Staff noted that the Company had failed to file its Annual Report on Form 10-K for the period ended December 31, 2023 (the “ 2023 Form 10-K ”), which serves”

OLENOX INDUSTRIES INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 19, 2024, Safe & Green Holdings Corp. (the “Company”) received a delinquency letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires timely filing of periodic reports with the Securities and Exchange Commission (the “SEC”) for continued listing. Nasdaq rules require public announcement to disclose the Company’s receipt of the Notice within four business days of receipt. In accordance with Nasdaq rules, the Company ha”

STREAMLINE HEALTH SOLUTIONS INC. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 22, 2024, to regain compliance with the Minimum Bid Price Requirement. On April 23, 2024, the Company received a letter from the Staff informing the Company that, while the Company has not regained compliance with the Minimum Bid Price Requirement, the Staff has determined that the Company is eligible for an additional 180 calendar day period, or until October 21, 2024 (the “Second Compliance Period”), to regain compliance. If at any time during the Second Compliance Period, the closing bid price of the Common Stock is at least $1.00 per share for a minimum of 10 consecutive business day”

RenX Enterprises Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 25, 2024, Safe and Green Development Corporation (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days (March 14, 2024 through April 24, 2024), the Company’s common stock did not maintain a minimum closing bid price of $1.00 (“Minimum Bid Price Requirement”) per share as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trad”

Real Good Food Company, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(3)(C), 5810(c)(3)(D)).

“April 24, 2024, The Real Good Food Company Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that based on the market value of publicly held shares for the previous 30 consecutive business days, the listing of the Company’s common stock is not in compliance with Nasdaq Listing Rule 5450(b)(3)(C) to maintain a minimum market value of publicly held shares of $15,000,000 (the “MVPHS Rule”). Under Nasdaq Listing Rule 5810(c)(3)(D), the Company has a period of 180 calendar days, or until October 21, 2024, to regain”

Onyx Acquisition Co. I received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5450(b)(2)(B)).

“April 5, 2024, the Company received written notices from the Staff stating that the Company did not meet (a) the $15,000,000 minimum market value of publicly held shares required to maintain continued listing on the Nasdaq Global Market as set forth in Nasdaq’s Listing Rule 5450(b)(2)(C) for the 30-business day period ended April 3, 2024, and (b) the minimum 1,100,000 publicly held shares required to maintain continued listing as set forth in Nasdaq’s Listing Rule 5450(b)(2)(B). Upon the transfer of the listing of the Company’s Securities to the Nasdaq Capital Market, these Nasdaq Global Marke”

Bannix Acquisition Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 25, 2024, Bannix Acquisition Corp., a Delaware corporation (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Company’s Annual Report on Form 10-K for the year ended December 31, 2023, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). This notification has no immediate effect on the listing of the Company’s shares on Nasdaq.”

Goal Acquisitions Corp. received a nasdaq deficiency notice notice regarding other (rules 5550(b)(2), 5550(a)(4), 5250(f)).

“ating company as required under Nasdaq IM-5101, and the Company no longer satisfying the minimum $35 million market value of listed securities requirement and the minimum 500,000 publicly held shares requirement for continued inclusion on The Nasdaq Capital Market, as set forth Nasdaq Listing Rules 5550(b)(2) and 5550(a)(4), respectively, the Company has not paid certain fees required by Nasdaq Listing Rule 5250(f). While the Notice indicated that this additional deficiency could serve as an additional basis for delisting, the Notice also indicated that the Company may present its plan to evid”

BuzzFeed, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A)).

“(the “ Nasdaq Staff ”) that, as a consequence of Mr. Kerins’ failure to seek re-election, following the 2024 Annual Meeting, the audit committee of the Company's board of directors would consist of two members and, as such, that the Company would no longer be in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires that the audit committees of listed companies have a minimum of three members that satisfy certain criteria for service on the committee (the “ Nasdaq Audit Committee Requirement ”). As discussed below in”

Astra Space, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 23, 2024, the Company received a deficiency notice from Nasdaq that the Company is not in compliance with the minimum stockholders’ equity listing requirement set forth in Rule 5550(b)(1) (the “ Minimum Stockholders’ Equity Requirement ”) because its Annual Report on Form 10-K for the period ended December 31, 2023 filed with the SEC on April 18, 2024, reported stockholders’ equity below $2,500,000. Additionally, as of the date of this Report, the Company does not meet the alternative Nasdaq continued listing standards under Nasdaq Listing Rules. This notice of noncompliance has had no i”

FARADAY FUTURE INTELLIGENT ELECTRIC INC. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“April 18, 2024, Nasdaq notified the Company that since it had not yet filed its Form 10-K for the year ended December 31, 2023, it no longer complied with Listing Rule 5250(c)(1). Pursuant to Listing Rule 5810(c)(2)(A), this deficiency is now an additional basis for delisting. The Company intends to request a hearing to appeal the Delisting Determination by May 1, 2024, the latest date permitted, which will stay the suspension of the Company’s securities for 15 days from the date of the request, during which time the Company’s securities will continue to be listed on The Nasdaq Capital Market.”

FARADAY FUTURE INTELLIGENT ELECTRIC INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).

“April 24, 2024, Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) dated April 24, 2024, indicating that the Company was not in compliance with Nasdaq Listing Rule 5810(c)(3)(A)(iii), as the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days. The letter indicated that, as a result, the Nasdaq staff has determined to delist the Company’s securities from The Nasdaq Capital Market (the “Delisting Determination”). As previously reported, on December 28, 2023, Nasdaq notifi”

Next Technology Holding Inc. received a nasdaq deficiency notice notice regarding other (rules 5250(f)).

“April 24, 2024, Next Technology Holding Inc. (the “Company”) received a deficiency letter (the “Fee Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company had not paid certain fees required by Nasdaq Listing Rule 5250(f). The Company’s past due fee balance was $49,500 as of the date of the Fee Notice. The Fee Notice provided that if the Company elects not to appeal by May 1, 2024, then this lack of payment would lead to the suspension of the trading of the Company’s common stock at the opening of business on May 3, 2”

AMERICAN REBEL HOLDINGS INC received a nasdaq noncompliance notice notice regarding other (rules 5620(a)).

“February 28, 2024 the Registrant received a written notice from the Listing Qualifications department of The Nasdaq Stock Market stating that because the Company has not yet held an annual meeting of shareholders within 12 months of the end of the Registrant’s 2022 fiscal year end, it no longer complies with Nasdaq Listing Rule 5620(a) for continued listing on The Nasdaq Capital Market. The Registrant had until April 15, 2024, which was 45 days from the date of the notice, to submit a plan to regain compliance and, if Nasdaq accepted the plan, it may grant an exception of up to 180 calendar da”

Knightscope, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5505(b)).

“rice Requirement”). As previously disclosed, on October 26, 2023, the Company was listed on The Nasdaq Global Market and received written notice (the “Notice”) from Nasdaq indicating that the Company was no longer in compliance with the Minimum Bid Price Requirement set forth in Nasdaq Listing Rule 5450(a)(1) and had 180 calendar days, or until April 23, 2024, to regain compliance with the Minimum Bid Price Requirement. The Company transferred to The Nasdaq Capital Market effective as of March 4, 2024 and was afforded the remainder of the compliance period to regain compliance with the Minimum”